Sinovac Biotech (SVA) Reports Q2 Loss of $0.17

Sinovac Biotech (NASDAQ: SVA) reported Q2 EPS of ($0.17), versus $0.04 reported last year. Revenue for the quarter came in at $1.38 billion, versus $18.49 billion reported last year.

For earnings history and earnings-related data on Sinovac Biotech (SVA) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14